Noninvasive Prenatal Screening Test: A New Screening Option for High Risk Pregnant Women
Presented by: Tina Mladenka, DNP, APRN, CNP, WHNP- BC
Presented by: Christina Murphey, PhD, RNC-OB
Tina Mladenka is a Women's Health Nurse Practitioner who currently provides reproductive health services at Southeastern Idaho Public Health in Pocatello, ID. She is a NIH/NINR Fellow of the Summer Genetics Institute 2007 and is currently serving as Co-Chair for the ISONG Perinatal Nursing SIG. Dr. Mladenka has worked in a variety of practice, academic, and teaching roles in the areas of perinatal, reproductive, and women's health and health care genomics.
Christina Murphey is an Assistant Professor and Director of the Graduate Maternity Program at The University of Texas at Austin, School of Nursing. She is a NIH/ NINR Fellow of the Summer Genetics Institute and has is currently serving as Co-Chair for the ISONG Perinatal Nursing SIG. Dr. Murphey has worked in a variety of research, academic, and teaching roles in the areas of health care genomics and perinatal health promotion.
Noninvasive prenatal screening test (NIPS) is a new option in prenatal testing that screens for trisomy 21 and other fetal chromosomal abnormalities. It analyzes cell-free fetal DNA from a sample of maternal blood. This webinar will provide information about noninvasive prenatal screening, including a description of the test, accuracy of the test, its advantages and limitations, indications for the test, pre- and post-test counseling, how it is different than current prenatal screening tests, ethical and legal implications of the test, and current professional recommendations for the test.
Who Should Attend?
Nurses, nurse practitioners, and other interdisciplinary health care providers who have minimal experience or educational preparation in genetics and are involved in prenatal care and/or want to know more information about noninvasive prenatal screening test for professional and personal reasons.
1. Explain 3 key concepts regarding the noninvasive prenatal screening test (NIPS)
2. Describe how NIPS test is different than current prenatal screening tests.
3. Identify clients to whom NIPS test should be offered.
4. Explain current professional recommendations for NIPS test.
5. Describe basic ethical and legal aspects of NIPS
The cost is $25.00 for ISONG Members / $50.00 for Non-members.
This learning activity has been developed in collaboration with the University of Pittsburgh School of Nursing.
Participants successfully completing this activity will be awarded one (1) continuing nursing education contact hour.
The University of Pittsburgh School of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation